Key result
Visceral adiposity index was independently associated with hyperuricemia in males free of metabolic syndrome, with the highest quartile having an OR of 3.041 compared to the lowest quartile.
Why the study?
Does a higher visceral adiposity index increase the risk of hyperuricemia in males free of metabolic syndrome?
Cross-Sectional (n=633)
No
Does a higher visceral adiposity index increase the risk of hyperuricemia in males free of metabolic syndrome?
Visceral adiposity index is an independent predictor of hyperuricemia in men without metabolic syndrome, demonstrating better predictive accuracy than waist circumference or BMI.
Answers are grounded in this paper and cite their sources.
VAI may aid hyperuricemia risk stratification in men without MetS; hypothesis-generating and requires prospective validation.
BACKGROUND: Visceral adiposity index (VAI) was closely associated with metabolic syndrome, however almost no research focused on VAI and hyperuricemia, therefore, this study was conducted to determine the relationship of VAI and hyperuricemia free of metabolic syndrome and estimate the power of VAI as predictor for hyperuricemia. METHODS: A cross-sectional research coming from a health check-up program was conducted. All participants were divided into four groups according to VAI quartiles. A multivariate logistic analysis was used to analyze the relationship between the quartiles and hyperuricemia. A receiver operating characteristic (ROC) curve analysis was used to evaluate the accuracy of predictions for hyperuricemia. RESULTS: VAI was independent risk factor of hyperuricemia. The ORs of which in the upper quartile were 3.077 (95%CI 1.78-5.293), P = 0.000, in model 1, after adjusting for age, systolic blood pressure, diastolic blood pressure, heart rate, fast plasma glucose, serum creatinine, triglyceride, total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol; and 3.041 (95CI 1.767-5.233), P = 0.000, in model 2, after adjusting for the above plus physical activity, diet, smoking habits, alcohol consumption, hypertension and diabetes history. The area under the ROC curve (AUC) value of VAI was 0.618 (95%CI 0.572-0.665), P = 0.000; it was higher than WC, which was 0.556 (95%CI 0.508-0.604), P = 0.024, for hyperuricemia. CONCLUSIONS: VAI was associated with hyperuricemia among individuals free of metabolic syndrome, and also a powerful indicator.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2018) conducted a cross-sectional in Hyperuricemia (n=633). Visceral adiposity index (VAI) vs. Lower quartile of VAI was evaluated on Hyperuricemia (OR 3.041, 95% CI 1.767-5.233, p=0.000). Visceral adiposity index was independently associated with hyperuricemia in males free of metabolic syndrome, with the highest quartile having an OR of 3.041 compared to the lowest quartile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: